Research area · Short-peptide research

Bioregulators: what the word means.

"Bioregulator" is a name some sellers and researchers use for very short peptides, such as epitalon. It is a description, not a legal category: in its 2026 compounding reviews, the FDA assessed each peptide on its own.

  • Evidence grade or review status for every compound
  • Sources listed on every page
  • US and sport status, dated
1 compoundReview in progress
Updated Nov 2026Dated on every page
EPITALON
Short answerResearch area · Updated 18 Nov 2026

"Bioregulator" is a name some sellers and researchers use for very short peptides, such as epitalon. It is a description, not a legal category: in its 2026 compounding reviews, the FDA assessed each peptide on its own. Evidence attaches to each compound studied, never to a label, and epitalon is not an FDA-approved medicine.

Compounds studied in this area

Grades describe the published evidence, not a promise of any effect.

The research so far

Is “bioregulator” a legal category?

Each peptide has its own legal status. In July 2026, for example, an FDA advisory committee voted to recommend epitalon for compounding, and the October HHS policy covers it; that says nothing about other short peptides sold as bioregulators. [1] [3] [2]

What doesn’t the research on bioregulators show?

Saying what we don't know is part of the evidence.

Anything about bioregulators as a group: evidence attaches to each compound studied, never to a label.

Is epitalon an FDA-approved medicine? US and sport status

As of November 2026. See the full tracker and the changelog.

CompoundFDA approval503A compounding (2026)WADA (2026 List)
EpitalonNot approvedFDA advisory committee voted for listing (Jul); HHS enforcement-discretion policy (Oct); no rule yetNot named; S0 covers unapproved substances

Worth knowing

Research use only

None of the compounds on this page is an FDA-approved medicine. Nothing on this page is medical advice or describes use in people.

What research use only means

No doses, ever

We publish no doses, protocols, or cycles for people, on any page.

Why we publish no doses

How we grade evidence

Grades follow study design: cell and animal studies (preclinical), small human studies, then controlled human trials, with approval tracked separately. A grade is not a promise of any effect.

Evidence grades

Questions people ask

Is a bioregulator a kind of medicine?

Not as a group. The word is a description used by sellers and some researchers, and the FDA's 2026 compounding reviews assessed each peptide on its own. Check each compound's legal status in our tracker.

How should I read a claim about bioregulators?

Ask which compound, which study, in which model, and how many subjects. If a claim names only the label, it has no evidence behind it on our pages.

Sources

  1. U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee meeting page, 23–24 July 2026: agenda, voting questions and FDA briefing (no minutes posted as of 17 November 2026). www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026
  2. U.S. Department of Health and Human Services. Enforcement discretion policy regarding 503A compounding using certain peptide bulk drug substances, 28 Oct 2026. www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy.pdf
  3. U.S. Department of Health and Human Services. Enforcement discretion policy, Appendix B: peptide identities and justifications, October 2026 (records the July 2026 committee outcome for each of the six peptides). www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy-appendix-b.pdf
  4. Anisimov VN, Khavinson VKh. Peptide bioregulation of aging: results and prospects. Biogerontology. 2010;11(2):139–149. PMID 19830585 (uses the term "peptide bioregulators"). pubmed.ncbi.nlm.nih.gov/19830585/

Start with the evidence

Every page sourced and dated, including what the research does not show.

Open the research library
Written by 6AM Research. Drafted with AI from published studies, trial registries, and regulator documents, plus press reports where marked. Every page lists its sources and is dated. Editorial policy · Corrections
Education only. Nothing here is medical advice or describes use in people. Research use only